Noci Darlene sold $153K of NUVL
Noci Darlene (Chief Development Officer) sold 1,422 shares of Nuvalent, Inc. (NUVL) at $107.33 ($0.15M total) on 2026-05-28 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure updates the insider activity record but does not, by itself, change expected fundamentals or near-term catalysts.
Market read
Traders may note the insider sale for sentiment/positioning, but the 10b5-1 framing limits actionable signal strength.
What to watch
Sale size is modest relative to typical institutional flows; also consider whether other insiders filed contemporaneous buys/sells to contextualize directionality.
Background
This is an SEC Form 4 insider transaction disclosure for Nuvalent, Inc. (NUVL). The sale was executed under a pre-arranged Rule 10b5-1 plan.
Ticker impact
Nuvalent CDO Noci Darlene sold $152,623 of NUVL stock in an open-market transaction under a pre-arranged 10b5-1 plan.
Low near-term impact; any reaction is likely muted and short-lived.
The filing provides a concrete datapoint (sale size/date/price) but does not indicate new company-specific fundamentals; 10b5-1 plans typically reduce interpretive weight.
Market effects
Minimal; single-company insider transaction with no stated operational/regulatory/drug-trial update.
None indicated.
None indicated.
Counterpoint
Even with 10b5-1, repeated insider selling can coincide with management’s risk/valuation view; monitor for clustering of sales around catalysts.
Key entities
- issuerNuvalent, Inc.
Company whose shares were sold by an officer under a 10b5-1 plan.
- insiderNoci Darlene
Chief Development Officer who sold 1,422 shares at $107.33 on May 28, 2026.
